vs
Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $13.8M, roughly 1.3× CB Financial Services, Inc.). On growth, CB Financial Services, Inc. posted the faster year-over-year revenue change (19.9% vs -25.6%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $2.2M). Over the past eight quarters, CB Financial Services, Inc.'s revenue compounded faster (1.2% CAGR vs -10.1%).
CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CBFV vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $18.3M |
| Net Profit | — | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 38.1% | -2.2% |
| Net Margin | — | -3.0% |
| Revenue YoY | 19.9% | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | $0.90 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $18.3M | ||
| Q3 25 | $2.4M | $15.9M | ||
| Q2 25 | $13.5M | $16.1M | ||
| Q1 25 | $12.1M | $18.9M | ||
| Q4 24 | $13.2M | $24.7M | ||
| Q3 24 | $12.7M | $28.3M | ||
| Q2 24 | $12.2M | $25.8M | ||
| Q1 24 | $13.5M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $-5.7M | $-1.8M | ||
| Q2 25 | $3.9M | $-1.5M | ||
| Q1 25 | $1.9M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $3.2M | $1.7M | ||
| Q2 24 | $2.6M | $343.0K | ||
| Q1 24 | $4.2M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 38.1% | -2.2% | ||
| Q3 25 | -289.8% | -9.9% | ||
| Q2 25 | 35.0% | -8.4% | ||
| Q1 25 | 19.3% | -7.2% | ||
| Q4 24 | 23.1% | -2.1% | ||
| Q3 24 | 31.2% | 6.8% | ||
| Q2 24 | 26.4% | 2.0% | ||
| Q1 24 | 37.9% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | -235.2% | -11.0% | ||
| Q2 25 | 29.3% | -9.3% | ||
| Q1 25 | 15.8% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 25.3% | 5.9% | ||
| Q2 24 | 21.8% | 1.3% | ||
| Q1 24 | 31.1% | -7.6% |
| Q4 25 | $0.90 | $-0.01 | ||
| Q3 25 | $-1.07 | $-0.05 | ||
| Q2 25 | $0.74 | $-0.05 | ||
| Q1 25 | $0.35 | $-0.04 | ||
| Q4 24 | $0.45 | $-0.02 | ||
| Q3 24 | $0.60 | $0.04 | ||
| Q2 24 | $0.51 | $0.01 | ||
| Q1 24 | $0.82 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $157.5M | $37.0M |
| Total Assets | $1.5B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $10.7M | ||
| Q3 25 | $55.9M | $13.6M | ||
| Q2 25 | $64.5M | $12.5M | ||
| Q1 25 | $61.3M | $11.4M | ||
| Q4 24 | $49.6M | $15.7M | ||
| Q3 24 | $147.3M | $12.3M | ||
| Q2 24 | $142.6M | $11.9M | ||
| Q1 24 | $73.7M | $6.6M |
| Q4 25 | $157.5M | $37.0M | ||
| Q3 25 | $152.5M | $37.0M | ||
| Q2 25 | $148.4M | $30.4M | ||
| Q1 25 | $148.3M | $31.5M | ||
| Q4 24 | $147.4M | $32.6M | ||
| Q3 24 | $149.1M | $29.1M | ||
| Q2 24 | $142.9M | $23.5M | ||
| Q1 24 | $141.6M | $20.6M |
| Q4 25 | $1.5B | $57.1M | ||
| Q3 25 | $1.5B | $57.5M | ||
| Q2 25 | $1.5B | $52.6M | ||
| Q1 25 | $1.5B | $54.0M | ||
| Q4 24 | $1.5B | $59.2M | ||
| Q3 24 | $1.6B | $57.1M | ||
| Q2 24 | $1.6B | $53.0M | ||
| Q1 24 | $1.5B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $2.3M |
| Free Cash FlowOCF − Capex | $17.2M | $2.2M |
| FCF MarginFCF / Revenue | 124.1% | 12.0% |
| Capex IntensityCapex / Revenue | 4.7% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.5M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $2.3M | ||
| Q3 25 | $4.6M | $-1.3M | ||
| Q2 25 | $4.1M | $1.8M | ||
| Q1 25 | $4.0M | $-3.5M | ||
| Q4 24 | $6.8M | $865.0K | ||
| Q3 24 | $3.1M | $4.3M | ||
| Q2 24 | $-1.2M | $1.4M | ||
| Q1 24 | $3.3M | $-2.4M |
| Q4 25 | $17.2M | $2.2M | ||
| Q3 25 | $4.5M | $-1.5M | ||
| Q2 25 | $3.9M | $1.7M | ||
| Q1 25 | $3.9M | $-3.5M | ||
| Q4 24 | $3.4M | $470.0K | ||
| Q3 24 | $2.2M | $4.1M | ||
| Q2 24 | $-2.4M | $1.2M | ||
| Q1 24 | $2.3M | $-2.5M |
| Q4 25 | 124.1% | 12.0% | ||
| Q3 25 | 186.5% | -9.6% | ||
| Q2 25 | 28.8% | 10.5% | ||
| Q1 25 | 32.5% | -18.8% | ||
| Q4 24 | 26.0% | 1.9% | ||
| Q3 24 | 17.4% | 14.4% | ||
| Q2 24 | -19.6% | 4.5% | ||
| Q1 24 | 17.0% | -11.1% |
| Q4 25 | 4.7% | 0.5% | ||
| Q3 25 | 4.3% | 1.4% | ||
| Q2 25 | 1.9% | 1.0% | ||
| Q1 25 | 0.8% | 0.3% | ||
| Q4 24 | 25.1% | 1.6% | ||
| Q3 24 | 6.7% | 0.7% | ||
| Q2 24 | 10.0% | 1.1% | ||
| Q1 24 | 7.2% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.95× | 2.57× | ||
| Q2 24 | -0.44× | 4.20× | ||
| Q1 24 | 0.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBFV
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
